ChemoCentryx, Inc.·4

Mar 2, 5:46 PM ET

ChemoCentryx, Inc. 4

4 · ChemoCentryx, Inc. · Filed Mar 2, 2017

Insider Transaction Report

Form 4
Period: 2017-02-28
SINGH RAJINDER
SVP, Research
Transactions
  • Award

    Restricted Stock Units

    2017-02-28+30,00030,000 total
    Common Stock (30,000 underlying)
  • Award

    Stock Option (right to buy)

    2017-02-28+80,00080,000 total
    Exercise: $6.62Exp: 2027-02-28Common Stock (80,000 underlying)
Footnotes (4)
  • [F1]The option was granted on February 28, 2017. 25% of the total number of shares of common stock subject to the option will vest on January 1, 2018, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  • [F2]Not applicable.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
  • [F4]The restricted stock units vest in three equal installments on January 1, 2018, January 1, 2019, and January 1, 2020, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION